A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study
about
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study
description
im November 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2018
@uk
name
A multicenter REtrospective ob ...... t cancer patients. RePer Study
@en
A multicenter REtrospective ob ...... t cancer patients. RePer Study
@nl
type
label
A multicenter REtrospective ob ...... t cancer patients. RePer Study
@en
A multicenter REtrospective ob ...... t cancer patients. RePer Study
@nl
prefLabel
A multicenter REtrospective ob ...... t cancer patients. RePer Study
@en
A multicenter REtrospective ob ...... t cancer patients. RePer Study
@nl
P2093
P50
P1476
A multicenter REtrospective ob ...... t cancer patients. RePer Study
@en
P2093
Agnese Latorre
Alain Gelibter
Alessandra Cassano
Andrea Botticelli
Angela Vaccaro
Angelo Fedele Scinto
Antonio Giordano
Carlo Garufi
Daniele Santini
Domenico Corsi
P304
P356
10.1080/15384047.2018.1523095
P407
P50
P577
2018-11-07T00:00:00Z